These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20332226)

  • 1. Kinome profiling of clinical cancer specimens.
    Parikh K; Peppelenbosch MP
    Cancer Res; 2010 Apr; 70(7):2575-8. PubMed ID: 20332226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
    Calvo KR; Liotta LA; Petricoin EF
    Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinome profiling using peptide arrays in eukaryotic cells.
    Parikh K; Peppelenbosch MP; Ritsema T
    Methods Mol Biol; 2009; 527():269-80, x. PubMed ID: 19241020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving in-depth proteomics profiling by mass spectrometry.
    Ahn NG; Shabb JB; Old WM; Resing KA
    ACS Chem Biol; 2007 Jan; 2(1):39-52. PubMed ID: 17243782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for kinome profiling in cancer and potential clinical applications: chemical proteomics and array-based methods.
    Piersma SR; Labots M; Verheul HM; Jiménez CR
    Anal Bioanal Chem; 2010 Aug; 397(8):3163-71. PubMed ID: 20526883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide arrays for kinome analysis: new opportunities and remaining challenges.
    Arsenault R; Griebel P; Napper S
    Proteomics; 2011 Dec; 11(24):4595-609. PubMed ID: 22002874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technological advances for interrogating the human kinome.
    Baharani A; Trost B; Kusalik A; Napper S
    Biochem Soc Trans; 2017 Feb; 45(1):65-77. PubMed ID: 28202660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteome analysis and tissue microarray for profiling protein markers associated with lymph node metastasis in colorectal cancer.
    Pei H; Zhu H; Zeng S; Li Y; Yang H; Shen L; Chen J; Zeng L; Fan J; Li X; Gong Y; Shen H
    J Proteome Res; 2007 Jul; 6(7):2495-501. PubMed ID: 17542627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
    Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF
    Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Micro-array based technologies to study the proteome: technological progress and applications].
    Mortuaire G; Marchetti P; Formstecher P; Danzé PM
    Ann Biol Clin (Paris); 2004; 62(2):139-48. PubMed ID: 15047465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-based proteomics: mapping of protein circuitries for diagnostics, prognostics, and therapy guidance in cancer.
    Gulmann C; Sheehan KM; Kay EW; Liotta LA; Petricoin EF
    J Pathol; 2006 Apr; 208(5):595-606. PubMed ID: 16518808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Data merging for integrated microarray and proteomic analysis.
    Waters KM; Pounds JG; Thrall BD
    Brief Funct Genomic Proteomic; 2006 Dec; 5(4):261-72. PubMed ID: 16772273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
    VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
    Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics and the haematologist.
    Rees-Unwin KS; Morgan GJ; Davies FE
    Clin Lab Haematol; 2004 Apr; 26(2):77-86. PubMed ID: 15053800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimizing targeted cancer therapy: towards clinical application of systems biology approaches.
    Sikkema AH; den Dunnen WF; Diks SH; Peppelenbosch MP; de Bont ES
    Crit Rev Oncol Hematol; 2012 May; 82(2):171-86. PubMed ID: 21641230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.